Skip to main content

iSpecimen Inc.

ISPC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001558569

No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding iSpecimen Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of ISPC: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders13130
Shares1.16M310.8K−849.2K (−73.2%)
Value$9.21M$1.98M−$7.23M (−78.5%)

New holders (6)

Institutions that held iSpecimen Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ISPC in Q1 2022
InstitutionSharesValue% of portfolio
Teton Advisors, Inc.40,000$215.0K0.04%
Grimes & Company, Inc.34,771$187.0K0.01%
Schonfeld Strategic Advisors LLC20,100$108.0K0.00%
Jane Street Group, LLC10,351$56.0K0.00%
Citigroup Inc1,750$9.00K0.00%
UBS Group AG572$3.00K0.00%

Sold out (6)

Institutions that held iSpecimen Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ISPC in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Empery Asset Management, LP466,333$3.64M
Kepos Capital LP190,000$1.48M
Engineers Gate Manager LP26,959$211.0K
Main Street Financial Solutions, LLC10,500$82.0K
Two Sigma Securities, LLC10,076$79.0K
Bank of America Corp2$0